Catalyst

Slingshot members are tracking this event:

Top-line results from the MEDALIST and BELIEVE Phase 3 trials of luspatercept are expected in mid-2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
XLRN

100%
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Myelodysplastic Syndromes, Beta-thalassemia, Phase 3 Study, Luspatercept